MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

Concomitant administration of radiotherapy with cisplatin or radiotherapy with cetuximab appear to be the treatment of choice for patients with locally advanced head and neck cancer. In the present retrospective analysis, we investigated the predictive role of several biomarkers in an unselected coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Fountzilas, George, Kalogera-Fountzila, Anna, Lambaki, Sophia, Wirtz, Ralph M., Nikolaou, Angelos, Karayannopoulou, Georgia, Bobos, Mattheos, Kotoula, Vassiliki, Murray, Samuel, Lambropoulos, Alexandros, Aravantinos, Gerasimos, Markou, Konstantinos, Athanassiou, Eleni, Misailidou, Despina, Kalogeras, Konstantine T., Skarlos, Demosthenis
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801452/
https://www.ncbi.nlm.nih.gov/pubmed/20066159
http://dx.doi.org/10.1155/2009/305908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801452/
https://www.ncbi.nlm.nih.gov/pubmed/20066159
http://dx.doi.org/10.1155/2009/305908

Ejemplares similares